Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
Do | Vivos Therapeutics Stock Climbs 9% On Positive Pediatric Sleep Apnea Study | - | RTTNews | ||
Do | Vivos Therapeutics, Inc: New Clinical Trial Data Published Showing Positive Results from Use of Vivos Technology to Treat Obstructive Sleep Apnea in Children | 1 | GlobeNewswire (USA) | ||
11.06. | Vivos Therapeutics Finalizes Acquisition Of The Sleep Center Of Nevada | 1 | RTTNews | ||
11.06. | Vivos Therapeutics, Inc: Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada | 145 | GlobeNewswire (Europe) | Transaction brings OSA diagnostic revenue to Vivos, plus Vivos' highly effective OSA treatment options to thousands of potential patients in the greater Las Vegas area Transaction also completes... ► Artikel lesen | |
06.06. | Vivos Therapeutics ernennt Baker Tilly nach Fusion zum neuen Wirtschaftsprüfer | 1 | Investing.com Deutsch | ||
06.06. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
23.05. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
16.05. | Vivos Therapeutics GAAP EPS of -$0.45 misses by $0.10, revenue of $3.02M misses by $1.18M | 3 | Seeking Alpha | ||
VIVOS THERAPEUTICS Aktie jetzt für 0€ handeln | |||||
16.05. | Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 | 1 | Seeking Alpha | ||
15.05. | Vivos Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.05. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update | 136 | GlobeNewswire (Europe) | Year-over-year product revenue increased 8%, and year-over-year operating expenses decreased 5% as Vivos sets the stage for its Sleep Center of Nevada acquisition and continued advancement of its... ► Artikel lesen | |
17.04. | Vivos Therapeutics, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
16.04. | Vivos Therapeutics to acquire operating assets of The Sleep Center of Nevada | 1 | Seeking Alpha | ||
16.04. | Vivos Therapeutics, Inc: Vivos Therapeutics Signs Definitive Agreement to Acquire Largest Sleep Center Operator in Nevada | 113 | GlobeNewswire (Europe) | By acquiring The Sleep Center of Nevada, Vivos expands its business model to make its OSA treatments available to thousands of patients in the greater Las Vegas metro area Acquisition expected to... ► Artikel lesen | |
31.03. | Vivos Therapeutics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
31.03. | Vivos Therapeutics GAAP EPS of -$2.22 misses by $0.20, revenue of $15.03M misses by $0.17M | 5 | Seeking Alpha | ||
31.03. | Vivos Therapeutics, Inc: Vivos Therapeutics Reports Full Year 2024 Financial Results and Provides Operational Update | 91 | GlobeNewswire (Europe) | Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo.... ► Artikel lesen | |
31.03. | Vivos Therapeutics, Inc. - 10-K, Annual Report | 3 | SEC Filings | ||
28.03. | Earnings Outlook For Vivos Therapeutics | 2 | Benzinga.com | ||
18.02. | Vivos Therapeutics, Inc: Vivos Therapeutics to Participate in Fireside Chat with Water Tower Research on February 18, 2025 at 12:00 pm ET. | 1 | GlobeNewswire (USA) |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
ECKERT & ZIEGLER | 67,40 | +1,35 % | Leichte Zugewinne bei der Eckert&Ziegler-Aktie (65,60 €) | Die Eckert&Ziegler-Aktie notiert heute etwas fester. Das Wertpapier kostete zuletzt 65,60 Euro. Eine Verteuerung in Höhe von 1,75 Euro erfreut derzeit die Aktionäre von Eckert&Ziegler. Zur Stunde kostet... ► Artikel lesen | |
INTUITIVE SURGICAL | 457,15 | +0,16 % | Intuitive Surgical Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
SYNLAB | 12,810 | 0,00 % | Synlab Aktie: BRUTALE PROGNOSE zwingt Anleger zum Handeln. So sollten Sie HEUTE reagieren! | ||
NUGEN MEDICAL DEVICES | 0,033 | +1,23 % | NuGen Medical Devices - Lillys Geschichte: Ein Teenager aus Nordkanada… | ||
CARDINAL HEALTH | 142,30 | +0,57 % | Cardinal Health stock hits all-time high at 166.3 USD | ||
PLUS THERAPEUTICS | 0,365 | 0,00 % | Plus Therapeutics Expects Meaningful Revenue Contributions From CNSide Diagnostics In 2026 | WASHINGTON (dpa-AFX) - Plus Therapeutics, Inc. (PSTV), a clinical-stage pharmaceutical company, expects the revenue contributions of CNSide Diagnostics, LLC to 'become meaningful' in fiscal... ► Artikel lesen | |
ATOSSA THERAPEUTICS | 0,704 | -5,38 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
EVOFEM BIOSCIENCES | - | - | Windtree Therapeutics: Windtree Advances Lower Cost Manufacturing of PHEXXI, Evofem's Hormone-Free, On-Demand Prescription Contraceptive Gel | Windtree rapidly advancing lower cost PHEXXI manufacturing under March 2025 sourcing agreement Contract inked with outside U.S manufacturer to cut PHEXXI manufacturing costs by over 50% by end of... ► Artikel lesen | |
UNIDOC HEALTH | 0,125 | -9,28 % | UniDoc Health Corp.: UniDoc Provides Update on Marketing Engagement | VANCOUVER, BC / ACCESS Newswire / April 29, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), provides an update on its renewed engagement of Rumble Strip Media... ► Artikel lesen | |
PROGYNY | 21,460 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
PROCEPT BIOROBOTICS | 58,63 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 22,000 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
ADAPTHEALTH | 9,420 | 0,00 % | AdaptHealth Corp. - 10-K/A, Annual Report | ||
SIEMENS HEALTHINEERS | 46,670 | -0,36 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen |